previous compound ID: 1221 next compound
InChIKey: KVRQGMOSZKPBNS-FMHLWDFHSA-N
SMILES: C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)OC(=O)/C=C/C4=CC=CC=C4

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "J Goepp" "D Rotin" "SD Macknight" "GW Carlile" "B Kus" "DY Thomas" "R Robert" "JW Hanrahan" "J Liao"

chemical graph of compound 1221





CID is 5281542
synonyms found at PubChem are:
Harpagoside, 19210-12-9, UNII-8KGS1DC5ZU, 8KGS1DC5ZU, CHEBI:5625, SMR001233395, E-harpagoside, EINECS 242-881-6, AC1NQYLY, Prestwick3_000988, BSPBio_001055, MLS002154086, MLS002473324, SCHEMBL893387, BPBio1_001161, CHEMBL516702, MEGxp0_000469, Harpagoside, analytical standard, ACon0_000056, ACon1_000134, KVRQGMOSZKPBNS-FMHLWDFHSA-N, MolPort-001-740-640, HMS2098E17, HMS2231N12, ZINC8214398, AKOS015896715, LMPR0102070010, MCULE-8388168328, NCGC00179325-01, NCGC00179325-02, NCGC00179325-04, 4CN-1249, SC-19416, AB00513986, V0696, C09783, 210H129, I07-0170, Q-100231, BRD-K07996107-001-01-7, BRD-K07996107-001-03-3, Harpagoside, primary pharmaceutical reference standard, Harpagoside, European Pharmacopoeia (EP) Reference Standard, (1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate, (1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside, [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate, b-D-Glucopyranoside,(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl